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Reply to “‘Tolerance’ of Misused Terminology? Enforcing
Standardized Phenotypic Definitions”
Jakob Haaber,a,b Hanne Ingmer,a Stanley N. Cohenb
Department of Veterinary Disease Biology, University of Copenhagen, Frederiksberg, Denmarka; Department of Genetics, Stanford University, Stanford, California, USAb
We thank Dimitrijovski and co-authors for their interest inour recent paper “Reversible antibiotic tolerance induced in
Staphylococcus aureus by concurrent drug exposure” (2), but we
also wish to respond here to their comments about the terminol-
ogy and methods we’ve used.
Regarding terminology, Dimitrijovski and colleagues (1) ex-
press concern that our use of the term “tolerance” is not in accord
with what they state is the “official definition” by the Clinical and
Laboratory Standards Institute (CLSI) of “a vancomycin-tolerant
strain as one for which the minimum bactericidal concentration
(MBC)-to-MIC ratio is 32 after 24 h of incubation.” We cer-
tainly agree to the importance of having uniform terminology;
however, we are not aware that the testing standards developed by
CLSI to accomplish their stated mission of facilitating comparison
of data from different laboratories have been adopted as part of an
“official” nomenclature, and in fact not all references cited by
Dimitrijovski et al. adhere to what they have termed the official
definition. In any case, as explained in the text of our paper (2),
our use of the term “tolerance” was intended to distinguish
noninherited, reduced antibiotic susceptibility from resis-
tance, which commonly is used to indicate inherited reduced
susceptibility that is mutational in origin (for example, also see
reference 3).
Dimitrijovski et al. also question our conclusion that colistin
induces a VISA-like phenotype, noting that “VISA is defined ei-
ther by an MIC between 4 and 8 g/ml (FPR3757 MICs were
within the susceptible range,2g/ml) or by population analysis
profiling.” This concern is puzzling, as our paper states that the
characteristics of colistin-induced bacteria are not identical to
those of VISA strains but rather that exposure to colistin results in
some of the phenotypic changes common to VISA, and also that
the genes induced by colistin have very significant overlap with
those reported previously to be altered in VISA strains. Therefore,
we used the term “VISA-like” rather than “VISA.” As we reported,
the MIC of vancomycin for bacteria exposed to colistin is not in
the range observed for VISA strains. We also showed (see Fig. 4 of
our paper [2]) and noted explicitly in the text that thickening of
the cell wall, which as correctly stated by Dimitrijovski et al. is a
feature of VISA strains, was not observed in the colistin-induced
bacteria showing other phenotypic characteristics in common
with VISA.
The additional notion of Dimitrijovski et al. that our paper
concludes that colistin induces development of resistance or the
emergence of VISA is especially puzzling, as no such conclusions
were in fact made. We sincerely regret an apparent misinterpreta-
tion of our conclusions by at least some readers. Finally, Dimitri-
jovski et al. raise the concern that we used 2 g/ml daptomycin
instead of the official MIC breakpoint of 1g/ml to conclude that
colistin exposure does not affect bacterial susceptibility to dapto-
mycin. However, the MIC breakpoint seems to us to not be rele-
vant to the test (i.e., colony formation) that we employed in this
experiment. The mechanisms leading to reduced susceptibility to
daptomycin are complex and may be induced by multiple pro-
cesses (4), which may explain why the colistin exposure leads to
reduced negative cell surface charge without affecting daptomycin
susceptibility.
Dimitrijovski et al. share the concerns raised in our paper
about the possible induction of reversible reduced antimicrobial
susceptibility by certain combination therapy regimens, and agree
with the need for further investigations of reversible resistance.
Hopefully, our findings will help to encourage such investigations.
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